Viveve Medical Inc buy melinda
Startpreis
30.08.18
/
50%
2,95 ?
Kursziel
18.10.18
5,86 €
Rendite (%)
10,09 %
Endpreis
18.10.18
3,25 €
Zusammenfassung
Diese Einschätzung wurde am 18.10.18 mit einem Endkurs von 3,25 € beendet. Die Einschätzung konnte insgesamt eine Rendite von 10,09 % verzeichnen. melinda hat 50% Zuversicht bei dieser Einschätzung
Finanztrends
Rendite ohne Dividenden (%)
| Name | 1W | 1M | 1J | 3J |
|---|---|---|---|---|
| Viveve Medical Inc | - | - | - | - |
| iShares Core DAX® | 1,28 % | 1,32 % | 13,60 % | 15,78 % |
| iShares Nasdaq 100 | -2,46 % | -5,19 % | 25,94 % | 38,43 % |
| iShares Nikkei 225® | -2,01 % | -1,39 % | 8,97 % | 6,57 % |
| iShares S&P 500 | -0,66 % | -1,88 % | 23,68 % | 39,61 % |
Kommentare von melinda zu dieser Einschätzung
In der Diskussion Viveve Medical Inc diskutieren
SecteurEquipement et technologie médicale avancés Agenda 08/11 Publication de résultats
Engages in providing health care services
Viveve Medical, Inc. engages in the provision of health products.
Its activities include development and distribution of women's health solutions.
Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue.
The company was founded on March 3, 1987 and is headquartered Englewood, CO.
Viveve Medical, Inc. engages in the provision of health products.
Its activities include development and distribution of women's health solutions.
Its products include non-surgical, non-ablative medical device that remodels collagen and restores vaginal tissue.
The company was founded on March 3, 1987 and is headquartered Englewood, CO.
Nombre d'employés : 103 personnes.
(Vom Mitglied beendet)